Method for the molecular cytogenetic visualization of fragile site FRAXA
- 48 Downloads
Fragile X syndrome is one of the most common reasons for human hereditary mental retardation. It is associated with the expansion of CGG repeats in the 5'-untranslated region of the FMR1 gene, which results in the suppression of its expression and the development of the disease. At present, methods based on PCR and Southern blot analysis are used for diagnostics of the fragile X syndrome. The presence of a fragile site FRAXA on the X chromosome is typical for patients with this pathology. We developed a method of visualizing this site in cell cultures obtained from patients using the fluorescent in situ hybridization (FISH) and the combination of two probes. The method allows one to detect five types of signals on the X chromosome, three of which are normal, while two are associated with the emergence of fragile site FRAXA. An analysis of the distribution of all signal types in cell lines from healthy individuals and patients with fragile X syndrome demonstrated that the method allows one to determine differences between lines with a high statistical significance and that it is applicable to detecting cells that are carriers of the syndrome.
Keywordsfragile X syndrome mental retardation chromosome fragility FRAXA FMR1 fluorescent in situ hybridization
fragile X syndrome
fluorescent in situ hybridization
Unable to display preview. Download preview PDF.
- 5.Monaghan K.G., Lyon E., Spector E. 2013. ACMG standards and guidelines for fragile X testing: A revision to the disease-specific supplements to the standards and guidelines for clinical genetics laboratories of the American college of medical genetics and genomics. Genet. Med. 15, 575–586.CrossRefPubMedGoogle Scholar
- 8.Biancalana V., Steinbach P., Stenhouse S. 2006. Draft best practice guidelines for molecular analysis in fragile X syndrome. Eur. Mol. Genet. Quality Network. http://www.emqn.org/emqn/digitalAssets/0/233_EMQN_guidelines_FRAX_2006.pdf.Google Scholar
- 10.Saluto A., Brussino A., Tassone F., Arduino C., Cagnoli C., Pappi P., Hagerman P., Migone N., Brusco A. 2005. An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene. J. Mol. Diagn. 7, 605–612.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Filipovic-Sadic S., Sah S., Chen L., Krosting J., Sekinger E., Zhang W., Hagerman P.J., Stenzel T.T., Hadd A., Latham G.J., Tassone F. 2010. A novel FMR1 PCR method for the routine detection of low-abundance expanded alleles and full mutations in fragile X syndrome. Clin. Chem. 56, 399–408.PubMedPubMedCentralGoogle Scholar
- 13.Seneca S., Lissens W., Endels K., Caljon B., Bonduelle M., Keymolen K., de Rademaeker M., Ullmann U., Haentjens P., Van Berkel K., Van Dooren S. 2012. Reliable and sensitive detection of fragile X (expanded) alleles in clinical prenatal DNA samples with a fast turnaround time. J. Mol. Diagn. 14, 560–568.CrossRefPubMedGoogle Scholar
- 19.Strelnikov V.V., Nemtsova M.V., Chesnokova G.G., Kuleshov N.P., Zaletaev D.V. 1999. Diagnosis of the Martin–Bell syndrome based on structural and functional alterations in the 5'-untranslated region of the FMR1 gene. Mol. Biol. (Moscow). 33 (2) 288–294.Google Scholar
- 23.Grasso M., Boon E.M.J., Filipovic-Sadic S., Van Bunderen P.A., Gennaro E., Cao R., Latham G.J., Hadd A.G., Coviello D.A. 2014. A novel methylation PCR that offers standardized determination of FMR1 methylation and CGG repeat length without southern blot analysis. J. Mol. Diagn. 16, 23–31.CrossRefPubMedPubMedCentralGoogle Scholar